Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study

OBJECTIVE: The treatment outcome of direct-acting antivirals (DAAs) in chronic hepatitis C patients with hepatocellular carcinoma (HCC) is controversial. The current study aimed to address the treatment efficacy and safety of DAAs in patients with curative or active HCC, compared with those of patie...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Open
Asıl Yazarlar: Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Ching-I, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Wei, Yu-Ju, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2019
Konular:
Gastroenterology and Hepatology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501994/
https://ncbi.nlm.nih.gov/pubmed/31061041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-026703
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller